Axotide Diskus 100
Axotide Diskus 100 is a medicine authorised by Swissmedic under authorisation number 53390. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 August 1995 and the authorisation is valid without a time limit. ATC code R03BA05 places the medicine in the group Drugs for obstructive airway diseases.
| Authorisation number | 53390 |
|---|---|
| Name | Axotide Diskus 100 |
| Full name | Axotide Diskus 100, Mutlidosen-Pulverinhalator |
| Authorisation holder | GlaxoSmithKline AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | R03BA05 |
| First authorisation | 29 August 1995 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Axotide Diskus 100, Mutlidosen-Pulverinhalator | B | 29 August 1995 |
| 2 | Axotide Diskus 250, Mutlidosen-Pulverinhalator | B | 29 August 1995 |
| 3 | Axotide Diskus 500, Mutlidosen-Pulverinhalator | B | 29 August 1995 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 13 | 60 | Inhalationen | R03BA05 | 03.04.4. | B |
| 21 | 60 | Inhalationen | R03BA05 | 03.04.4. | B |
| 48 | 60 | Inhalationen | R03BA05 | 03.04.4. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Axotide Diskus 100 authorised in Switzerland?
Yes. Axotide Diskus 100 is authorised by Swissmedic under authorisation number 53390, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Axotide Diskus 100 have?
Axotide Diskus 100 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Axotide Diskus 100?
The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.